{
    "nctId": "NCT06595316",
    "briefTitle": "Exercise for Ameliorating Chemotherapy Cardiotoxicity",
    "officialTitle": "A Randomized Controlled Feasibility Trial of a Vigorous Intensity Aerobic Exercise and Resistance Training Intervention for Mitigating Chemotherapy Cardiotoxicity in Breast Cancer Patients",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Cardiotoxicity",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "Quantitative Feasibility Log of Eligibility of Participants.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Females between 18 to 75 years old.\n* Confirmed early stage (I-III) ER+ HER2 - breast cancer diagnosis\n* Undergoing adjuvant and neoadjuvant chemotherapy, consisting of epirubicin and cyclophosphamide (EC) followed by Docetaxel.\n* No contraindications to engage in physical activity.\n* Capable of giving informed consent.\n* Patients able to understand and communicate in English language\n\nExclusion Criteria:\n\n* Participants with cognitive disorders\n* Cancer metastases\n* Uncontrolled or serious illnesses that might hamper patients' capacity of exercising",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}